DESIGN , SETTING , AND OBJECTIVES : This randomized , double-blind , placebo-controlled outpatient study evaluated effects of once-monthly oral ibandronate on hip and lumbar spine BMD and calculated strength using quantitative computed tomography ( QCT ) with finite element analysis ( FEA ) and dual-energy x-ray absorptiometry ( DXA ) with hip structural analysis ( HSA ) .
